1 day Ago By ABMN Staff
StockNews.com upgraded shares of Prestige Consumer Healthcare ( NYSE:PBH – Free Report ) from a hold rating to a buy rating in a research report sent to investors on Tuesday. Several other research firms have also issued reports on PBH.
Royal Bank of Canada upped their price objective on Prestige Consumer Healthcare from $96.00 to $97.00 and gave the company a “sector perform” rating in a research note on Friday, March 21st.
Oppenheimer increased their target price on Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an “outperform” rating in a research note on Thursday, February 13th.
DA Davidson increased their target price on Prestige Consumer Healthcare from $95.00 to $104.00 and gave the stock a “buy” rating in a research note on Friday, February 7th.
Finally, Canaccord Genuity Group increased their target price on Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a “buy” rating in a research note on Friday, February 7th.
Three analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $93.33.
View Our Latest Analysis on Prestige Consumer Healthcare Prestige Consumer Healthcare Price Performance Prestige Consumer Healthcare ( NYSE:PBH – Get Free Report ) last released its quarterly earnings data on Thursday, February 6th. The company reported $1.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.
18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.
36% and a net margin of 19.13%. On average, analysts anticipate that Prestige Consumer Healthcare will post 4.
5 earnings per share for the current year. Insider Buying and Selling In related news, SVP Mary Beth Fritz sold 1,678 shares of the stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $90.
00, for a total transaction of $151,020.00. Following the sale, the senior vice president now owns 17,157 shares of the company’s stock, valued at $1,544,130.
This represents a 8.91 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website .
1.60% of the stock is currently owned by company insiders. Institutional Investors Weigh In On Prestige Consumer Healthcare A number of large investors have recently added to or reduced their stakes in the stock.
Envestnet Asset Management Inc. boosted its holdings in shares of Prestige Consumer Healthcare by 6.4% in the 1st quarter.
Envestnet Asset Management Inc. now owns 180,802 shares of the company’s stock valued at $15,544,000 after purchasing an additional 10,876 shares in the last quarter. Concurrent Investment Advisors LLC acquired a new stake in shares of Prestige Consumer Healthcare in the 1st quarter valued at $361,000.
Principal Financial Group Inc. boosted its holdings in shares of Prestige Consumer Healthcare by 3.2% in the 1st quarter.
Principal Financial Group Inc. now owns 264,817 shares of the company’s stock valued at $22,766,000 after purchasing an additional 8,291 shares in the last quarter. Meritage Portfolio Management boosted its holdings in shares of Prestige Consumer Healthcare by 6.
8% in the 1st quarter. Meritage Portfolio Management now owns 13,702 shares of the company’s stock valued at $1,178,000 after purchasing an additional 876 shares in the last quarter. Finally, KBC Group NV boosted its holdings in shares of Prestige Consumer Healthcare by 7.
4% in the 1st quarter. KBC Group NV now owns 2,199 shares of the company’s stock valued at $189,000 after purchasing an additional 151 shares in the last quarter. Institutional investors and hedge funds own 99.
95% of the company’s stock. Prestige Consumer Healthcare Company Profile ( Get Free Report ) Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.
See Also Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter ..
